{
    "schema": 1,
    "fid": "tesamorelin",
    "type": "article",
    "object_id": 500,
    "title": "Tesamorelin: Reference Overview and Reconstitution Notes",
    "entity": "Tesamorelin: Reference Overview and Reconstitution Notes",
    "url": "https://www.preppinpeppers.com/blogs/the-lab/tesamorelin",
    "facts_url": "https://www.preppinpeppers.com/facts/tesamorelin",
    "currency": null,
    "tldr": "Tesamorelin is a synthetic analog of growth-hormone-releasing factor (GHRH), a 44-amino-acid human protein, in the secretagogue class. Reconstitution notes.",
    "facts": [
        {
            "id": "tesamorelin:title",
            "category": "identity",
            "entity": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "attribute": "title",
            "value": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/tesamorelin"
        },
        {
            "id": "tesamorelin:published",
            "category": "identity",
            "entity": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "attribute": "published",
            "value": "2026-08-15",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/tesamorelin"
        },
        {
            "id": "tesamorelin:author",
            "category": "identity",
            "entity": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "attribute": "author",
            "value": "Preppin' Peppers Editorial Team",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/tesamorelin"
        },
        {
            "id": "tesamorelin:topics",
            "category": "identity",
            "entity": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "attribute": "topics",
            "value": "FDA-approved or specific-use, research",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/tesamorelin"
        },
        {
            "id": "tesamorelin:summary",
            "category": "content",
            "entity": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "attribute": "summary",
            "value": "Tesamorelin is a synthetic analog of growth-hormone-releasing factor (GHRH), a 44-amino-acid human protein, in the secretagogue class. Reconstitution notes.",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/tesamorelin"
        },
        {
            "id": "tesamorelin:section-1",
            "category": "content",
            "entity": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "What it is",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/tesamorelin"
        },
        {
            "id": "tesamorelin:section-2",
            "category": "content",
            "entity": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "What it is",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/tesamorelin"
        },
        {
            "id": "tesamorelin:section-3",
            "category": "content",
            "entity": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Research context and categorization",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/tesamorelin"
        },
        {
            "id": "tesamorelin:section-4",
            "category": "content",
            "entity": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Status",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/tesamorelin"
        },
        {
            "id": "tesamorelin:section-5",
            "category": "content",
            "entity": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Reconstitution notes (general)",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/tesamorelin"
        },
        {
            "id": "tesamorelin:section-6",
            "category": "content",
            "entity": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Dilution and handling notes (compound-specific)",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/tesamorelin"
        },
        {
            "id": "tesamorelin:section-7",
            "category": "content",
            "entity": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Handling and storage",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/tesamorelin"
        },
        {
            "id": "tesamorelin:section-8",
            "category": "content",
            "entity": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Related reading",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/tesamorelin"
        },
        {
            "id": "tesamorelin:section-9",
            "category": "content",
            "entity": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Tools and supplies",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/tesamorelin"
        },
        {
            "id": "tesamorelin:section-11",
            "category": "content",
            "entity": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "What the research community gets wrong about Tesamorelin",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/tesamorelin"
        },
        {
            "id": "tesamorelin:product-gansulin-metal-peptide-pen",
            "category": "products",
            "entity": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "attribute": "references product",
            "value": "Gansulin Pen · Reusable Click-Dial, 3 ml (1-60 Units)",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin)",
            "evidence": "https://www.preppinpeppers.com/products/gansulin-metal-peptide-pen"
        },
        {
            "id": "tesamorelin:product-gansulin-3ml-cartridge",
            "category": "products",
            "entity": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "attribute": "references product",
            "value": "Gansulin-Compatible 3 ml Glass Cartridge for Pens (10-Pack)",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin)",
            "evidence": "https://www.preppinpeppers.com/products/gansulin-3ml-cartridge"
        },
        {
            "id": "tesamorelin:source-pubchem-ncbi-nlm-nih-gov",
            "category": "source",
            "entity": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "attribute": "cites",
            "value": "NCBI PubChem CID 16137828: Tesamorelin (C221H366N72O67S) - pubchem.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin)",
            "evidence": "https://pubchem.ncbi.nlm.nih.gov/compound/16137828"
        },
        {
            "id": "tesamorelin:source-pubmed-ncbi-nlm-nih-gov",
            "category": "source",
            "entity": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "attribute": "cites",
            "value": "Falutz et al., N Engl J Med 2007: Metabolic effects of a growth hormone-releasing factor in patients with HIV - pubmed.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin)",
            "evidence": "https://pubmed.ncbi.nlm.nih.gov/18057338/"
        },
        {
            "id": "tesamorelin:source-dailymed-nlm-nih-gov",
            "category": "source",
            "entity": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "attribute": "cites",
            "value": "FDA/DailyMed: EGRIFTA SV (tesamorelin) label, indication and reconstitution - dailymed.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin)",
            "evidence": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3d783378-b02d-4f19-99dd-0fc91a042224"
        },
        {
            "id": "tesamorelin:source-pubmed-ncbi-nlm-nih-gov-2",
            "category": "source",
            "entity": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "attribute": "cites",
            "value": "Dhillon, Drugs 2011: Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy - pubmed.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin)",
            "evidence": "https://pubmed.ncbi.nlm.nih.gov/21668043/"
        },
        {
            "id": "tesamorelin:source-pmc-ncbi-nlm-nih-gov",
            "category": "source",
            "entity": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "attribute": "cites",
            "value": "Fourman et al., JCI Insight 2020: Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD - pmc.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin)",
            "evidence": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7455119/"
        },
        {
            "id": "tesamorelin:source-www-uniprot-org",
            "category": "source",
            "entity": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "attribute": "cites",
            "value": "UniProtKB/Swiss-Prot P01286: Somatoliberin (GHRH, Homo sapiens), UniProt release 2026-03 - www.uniprot.org",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/tesamorelin)",
            "evidence": "https://www.uniprot.org/uniprotkb/P01286/entry"
        }
    ],
    "buy": [],
    "faq": [
        {
            "q": "What makes Tesamorelin different from natural GHRH?",
            "a": "Tesamorelin shares GHRH's 44-amino-acid sequence but adds a hexenoyl group at one terminus, increasing resistance to enzymatic degradation and improving stability compared with the unmodified natural peptide."
        },
        {
            "q": "What is Tesamorelin's FDA approval and WADA classification?",
            "a": "It has one FDA approval: reducing excess visceral fat in HIV-associated lipodystrophy (brand: Egrifta). WADA lists it as prohibited at all times under S2—growth-hormone-releasing factors subclass."
        },
        {
            "q": "Why is Tesamorelin shipped as lyophilized powder?",
            "a": "Freeze-drying removes water to maximize shelf stability and minimize degradation during storage and transit. The powder is reconstituted with bacteriostatic water immediately before laboratory use."
        }
    ],
    "jsonld": [
        {
            "@context": "https://schema.org",
            "@type": "Article",
            "headline": "Tesamorelin: Reference Overview and Reconstitution Notes",
            "url": "https://www.preppinpeppers.com/blogs/the-lab/tesamorelin",
            "mainEntityOfPage": "https://www.preppinpeppers.com/blogs/the-lab/tesamorelin",
            "datePublished": "2026-08-15",
            "dateModified": "2026-10-16",
            "author": {
                "@type": "Person",
                "name": "Preppin' Peppers Editorial Team"
            },
            "publisher": {
                "@type": "Organization",
                "name": "PreppinPeppers"
            },
            "description": "Tesamorelin is a synthetic analog of growth-hormone-releasing factor (GHRH), a 44-amino-acid human protein, in the secretagogue class. Reconstitution notes."
        },
        {
            "@context": "https://schema.org",
            "@type": "FAQPage",
            "url": "https://www.preppinpeppers.com/facts/tesamorelin",
            "mainEntity": [
                {
                    "@type": "Question",
                    "name": "What makes Tesamorelin different from natural GHRH?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "Tesamorelin shares GHRH's 44-amino-acid sequence but adds a hexenoyl group at one terminus, increasing resistance to enzymatic degradation and improving stability compared with the unmodified natural peptide."
                    }
                },
                {
                    "@type": "Question",
                    "name": "What is Tesamorelin's FDA approval and WADA classification?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "It has one FDA approval: reducing excess visceral fat in HIV-associated lipodystrophy (brand: Egrifta). WADA lists it as prohibited at all times under S2—growth-hormone-releasing factors subclass."
                    }
                },
                {
                    "@type": "Question",
                    "name": "Why is Tesamorelin shipped as lyophilized powder?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "Freeze-drying removes water to maximize shelf stability and minimize degradation during storage and transit. The powder is reconstituted with bacteriostatic water immediately before laboratory use."
                    }
                }
            ]
        }
    ],
    "dates": {
        "published": "2026-08-15",
        "modified": "2026-10-16"
    }
}